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Abstract
Mitochondria in mammals are organized into tubular networks that undergo frequent shape change. Mitochondrial fission
and fusion are the main components mediating the mitochondrial shape change. Perturbation of the fission/fusion balance
is associated with many disease conditions. However, underlying mechanisms of the fission/fusion balance are not well
understood. Mitochondrial fission in mammals requires the dynamin-like protein DLP1/Drp1 that is recruited to the
mitochondrial surface, possibly through the membrane-anchored protein Fis1 or Mff. Additional dynamin-related GTPases,
mitofusin (Mfn) and OPA1, are associated with the outer and inner mitochondrial membranes, respectively, and mediate
fusion of the respective membranes. In this study, we found that two heptad-repeat regions (HR1 and HR2) of Mfn2 interact
with each other, and that Mfn2 also interacts with the fission protein DLP1. The association of the two heptad-repeats of
Mfn2 is fusion inhibitory whereas a positive role of the Mfn2/DLP1 interaction in mitochondrial fusion is suggested. Our
results imply that the differential binding of Mfn2-HR1 to HR2 and DLP1 regulates mitochondrial fusion and that DLP1 may
act as a regulatory factor for efficient execution of both fusion and fission of mitochondria.
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Introduction
Mitochondria in many cell types are organized into reticular
networks composed of filamentous tubules that frequently change
shape. Mitochondrial shape change is mediated mainly by fission
and fusion of mitochondrial tubules [1]. Multiple proteins have
been identified to mediate mitochondrial fission and fusion
processes [2]. The most notable proteins are the dynamin family
of large GTPases that remodel mitochondrial membranes during
the fission and fusion events. The dynamin-like protein DLP1/
Drp1 in mammals resides mostly in the cytosol and becomes
associated to the outer surface of mitochondria where it is
presumed to squeeze and sever the membrane tubule for fission
[3–5]. The small helix-rich mitochondrial outer membrane
protein Fis1 is likely to function as a receptor for DLP1
recruitment to mitochondria [6–9]. A recent report suggests that
a tail-anchored mitochondrial outer membrane protein, mito-
chondrial fission factor (Mff), may also function as a DLP1-
recruting molecule [10]. Additional dynamin-related GTPases,
Mitofusin (Mfn) and optic atrophy 1 (OPA1) are associated with
the mitochondrial outer and inner membranes, respectively, and
mediate fusion of respective membranes [11–16].
Under normal conditions, mitochondrial fission and fusion
occur in a balanced frequency and thus relatively constant tubular
morphology is maintained. However, perturbation of the fission/
fusion balance causes mitochondrial deformation and has been
found to be associated with numerous human diseases [17,18].
Defects in proteins involved in mitochondrial dynamics cause
Charcot-Marie-Tooth disease and autosomal dominant optic
atrophy [19–22]. In addition, genetic dysregulation of the
mitochondrial fusion protein Mfn2 has been associated with
vascular proliferative disorders [23], as well as obesity and type 2
diabetes [24]. While the functional significance of mitochondrial
fission and fusion is evident, the molecular mechanisms of how
mitochondrial fission and fusion are regulated are not fully
understood.
Mammalian cells have two mitofusin isoforms, Mfn1 and Mfn2
[25–28]. Both isoforms share a conserved molecular structure
containing the N-terminal GTPase domain, two regions of
hydrophobic heptad-repeat coiled-coil motifs, HR1 and HR2,
and two tandem transmembrane domains near the C-terminus
[11,29] (Fig. 1A). HR1- and HR2-containing regions lie at
opposite sides of the bipartite transmembrane domain that spans
the outer membrane twice, exposing the GTPase, HR1, and HR2
domains to the cytosol. Studies using Mfn1 showed that the C-
terminal HR2 region interacts with the HR2 of another molecule
[11]. The HR2/HR2 interaction has been shown to occur in an
anti-parallel manner, which allows tethering of the two mem-
branes for subsequent fusion of outer mitochondrial membranes
[11].
Intra- and inter-molecular interactions play an important role in
membrane remodeling action of dynamin family proteins [30–34].
In this study, we examined molecular interactions of the
mitochondrial fusion protein Mfn2. We identified an interaction
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association of the two heptad-repeats of Mfn2 is inhibitory of
fusion. Additionally, we discovered a previously unidentified
interaction between HR1 of Mfn2 and the C-terminal coiled-coil
domain of the fission protein DLP1, which was implicated in
promoting mitochondrial fusion. Similar to the previous report
showing a membrane-fission dynamin participating in yeast
vacuole fusion through interaction with a fusion t-SNARE [35],
our data demonstrate that the physical interaction between fission
and fusion proteins provides a novel mechanism for regulating
mitochondrial morphology.
Results
The N-terminal HR1 of Mfn2 interacts with the C-terminal
HR2 through the predicted coiled-coil region
We examined the molecular interactions of Mfn2 using yeast
two-hybrid (Y2H) analyses. The domains tested in Y2H analyses
include GTPase, HR1, HR2, GTPase-HR1, GTPase-HR2, HR1-
HR2, and full-length Mfn2 (Fig. 1A). Throughout this manuscript,
we refer to the N-terminal extension and GTPase domain as
‘‘GTPase’’, the rest of the N-terminal cytosolic domain as ‘‘HR1’’,
and the HR2-containing C-terminal cytosolic domain as ‘‘HR2’’
(Fig. 1A). For the full-length and HR1-HR2 constructs, we
replaced the transmembrane domain with polyglycine to avoid
mislocalization of the expressed proteins in Y2H analyses. In the
initial analyses using the full-length Mfn2 (Mfn2DTM) as bait and
individual domains as prey, we found that constructs containing
HR1, HR2, or both, interact with Mfn2DTM (Fig. 1B). While
these results were consistent with a previous report that showed an
interaction between the two HR2 domains of Mfn1 [11], our data
indicate that there is an interaction involving the HR1 domain of
Mfn2. The subsequent Y2H assays using individual GTPase,
HR1, and HR2 regions as both bait and prey showed that HR1
interacts with HR2 but little with HR1, whereas HR2 interacts
well with both HR1 and HR2 (Fig. 1C). Dilution series analyses
also revealed that HR1 interacts with HR2 (Fig. 1D). The HR1/
HR2 interaction appeared less strong compared to the HR2/HR2
interaction in this assay. Although we occasionally detected a
limited growth indicating a potential interaction between two HR1
domains, this interaction is currently inconclusive. We next
epitope-tagged HR1 and HR2 with Myc and HA, respectively,
Figure 1. Mfn2 HR1 interacts with HR2. (A) Mfn2 constructs used in Y2H analyses. The transmembrane region is substituted with polyglycine
(Mfn2DTM) to avoid the protein mislocalization. (B) Semi-quantitative Y2H assays using Mfn2DTM as bait and different Mfn2 domains as prey. HIS3
activity represented the strength of the bait-prey interaction and was assessed by percentage of colonies growing on histidine-lacking medium:
.75%, ++++; 50–75%, +++; 25–50%, ++; 0–25%, 6. Prey constructs containing HR1, HR2, or both interact with Mfn2DTM. (C and D) Y2H assays using
individual Mfn2 domains as bait and prey. Both semi-quantitative (C) and qualitative dilution series assays (D) show an interaction between HR1 and
HR2 in addition to the HR2/HR2 interaction.
doi:10.1371/journal.pone.0020655.g001
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transfected with both constructs. As shown in Fig. 2A, Myc-
HR1 was detected in the anti-HA immune complex along with
HA-HR2, indicating that the two domains interact with each
other. This result supports the Y2H data and indicates that the
HR1/HR2 interaction occurs in the cellular context.
In Y2H analyses using HR2 alone or HR1-HR2 as bait, and
either HR1 or HR2 as prey, we found that the HR1 binding to
bait containing both HR1 and HR2 in the same molecule was
markedly reduced (Fig. 2B). HR2 showed reduced binding to this
bait molecule as well, but the decrease was less pronounced
compared to the HR1 binding. Because HR1 can interact with
HR2, these results suggest that HR1 and HR2 are associated
within the bait molecule. In additional GST pull-down experi-
ments, when GST-HR2 was incubated with the mixture of both
HR1 and HR1-HR2, we found that more HR1 bound to GST-
HR2 than HR1-HR2, suggesting that the presence of HR1 and
HR2 in the same molecule decreases its binding to HR2
(supplemental Fig. S1A). While the configuration of homomeric
complexes of Mfn2 is currently unclear, it is possible that the
HR1/HR2 interaction occurs either intra-molecularly within the
same Mfn2 molecule, or inter-molecularly to form a dimeric or
multimeric configuration of Mfn2 proteins (Supplemental
Fig. S1B).
To further narrow down the region responsible for the HR1/
HR2 interaction, HR2 bindings to different regions of HR1 were
tested. Both semi-quantitative and dilution series Y2H assays
demonstrated that Mfn2[360–448] binds to the HR2 domain
(Fig. 2C and D). We also tested for the HR2 region, but any
further deletions within the HR2 abolished the HR1 binding,
Figure 2. Characterization of the Mfn2-HR1/HR2 interaction. (A) Co-immunoprecipitation of Mfn2-HR1 and HR2. Whole cell extract (WCE)
from BHK-21 cells co-transfected with Myc-tagged HR1 and HA-tagged HR2 was subjected to the anti-HA immunoprecipitation. Anti-Myc
immunoblotting shows the co-precipitation of Myc-HR1 (asterisk) with HA-HR2. Rabbit IgG was used as a negative control. (B) Association of HR1 and
HR2 within bait molecules. Y2H assays using bait containing both HR1 and HR2 in the same molecule (HR1-HR2) show a drastic decrease of HR1
(prey) binding compared to the HR2-only bait, indicating that HR1 and HR2 are preoccupied in bait molecules. The use of HR2 as prey displayed a
reduced binding as well although the extent of the decrease was not as great. (C and D) Y2H assays to narrow down the interaction regions within
the HR1 and HR2. Semi-quantitative (C) and dilution series (D) analyses demonstrate that Mfn2[360–448] interacts with the HR2 region.
doi:10.1371/journal.pone.0020655.g002
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with HR1 (Fig. 2C and D). Our data demonstrate that Mfn2[360–
448] that contains the HR1 coiled-coil motif interacts with HR2.
Mutations in the binding region of Mfn2-HR1
differentially affect mitochondrial morphology
Mfn2[360–448], which we identified as the region binding to
Mfn2-HR2, is predicted to contain three a-helical structures that
are potentially involved in protein interactions (Fig. 3A). To test
the role of these helices in interactions with Mfn2-HR2, we
generated three helix-breaking leucine-to-proline mutations,
L374P, L408P, and L441P, in each helix of Mfn2-HR1[360–
448] (Fig. 3A). Binding analyses by Y2H show that L374P and
L408P mutations disrupt the interactions with HR2 whereas the
L441P mutation maintains the HR1/HR2 interaction (Fig. 3B).
Using these HR1 mutants that have selective binding character-
istics to HR2, we tested their effects on the overall morphology of
mitochondria. Individual Myc-tagged full-length Mfn2 mutants
were expressed in cells for morphological analyses. Overexpression
of wild-type Mfn2 induced mitochondrial elongation in addition to
forming mitochondrial clusters as previously reported [25,36,37]
(Fig. 3E, F). Cells transfected with the Mfn2-L374P or Mfn2-
L408P mutant showed mitochondrial phenotypes similar to those
with the wild-type Mfn2. A large number of cells displayed overly
elongated and entangled mitochondrial tubules (Fig. 3G, H).
These mutants showed an increased number of cells containing
elongated mitochondria compared to wild-type Mfn2 (Fig. 3C),
suggesting that abolishing the HR1/HR2 interaction might
enhance mitochondrial fusion. A completely opposite phenotype
was observed in cells overexpressing Mfn2 containing the L441P
mutation that maintains the HR1/HR2 interaction. These cells
contained finely fragmented mitochondria (Fig. 3I), indicating a
dominant-negative effect of the Mfn2-L441P mutant. Because this
mutation maintains the HR1/HR2 interaction, this result suggests
that the HR1/HR2 interaction has an inhibitory role in
mitochondrial fusion. Computer-assisted morphometric analyses
of mitochondrial morphologies demonstrate that mitochondria in
cells expressing Mfn2-WT, L374P or L408P have increased values
of both aspect ratio and form factor compared to untransfected
cells. However, those cells expressing Mfn2-L441P show the value
close to 1 for small circular morphology (Supplemental Fig. S2). In
addition, the number of mitochondria increased in the Mfn2-
L441P mutant-expressing cells while decreasing with the expres-
sion of the other mutants and wild type Mfn2, indicating
mitochondrial fragmentation and the increased fusion, respectively
(Supplemental Fig. S2).
Mfn2 with the HR1/HR2 association is incompetent for
mitochondrial fusion
To specifically address the mitochondrial fusion capacity
affected by these Mfn2 mutations, we used Mfn double knockout
(DKO) mouse embryonic fibroblasts [11]. Mfn DKO cells contain
fragmented mitochondria due to a lack of mitochondrial fusion
(Fig. 4A), and expression of wild-type Mfn2 in these cells restores
the fusion activity and forms tubular mitochondria [11] (Fig. 4B
and C–C’’). It was noted that tightly clustered mitochondria were
still formed in about a half of the Mfn DKO cells transfected with
Mfn2 (Fig. 4B). Next, we expressed individual mutants in Mfn
DKO cells and examined mitochondrial morphology. We found
that expression of Mfn2-L374P and Mfn2-L408P restored the
tubular mitochondria in Mfn DKO cells (Fig. 4B, D–D’’, E–E’’),
indicating that these mutant Mfn2 proteins are capable of
mediating mitochondrial fusion. Because both mutations disrupt
the Mfn2-HR1/HR2 interaction, this result suggests that the
HR1/HR2 interaction is not necessary for mitochondrial fusion.
On the other hand, the Mfn2-L441P mutation that maintains the
HR1/HR2 interaction did not restore tubular mitochondria in
Mfn DKO cells (Fig. 4B, F–F’’). The majority of cells transfected
with Mfn2-L441P still contained completely fragmented mito-
chondria, indicating that this Mfn2 mutant is fusion incompetent
(Fig. 4B). The fusion incompetence caused by the L441P mutation
suggests that dissociating the HR1/HR2 interaction is necessary
for mitochondrial fusion.
Overexpression of Mfn2-HR1 elongates mitochondrial
tubules
The HR2/HR2 interaction of Mfn molecules has been shown
to mediate tethering of opposing mitochondria prior to the
membrane fusion [11]. Based on our morphological data using the
HR1 mutations, the HR1/HR2 association sequesters HR2 away
from the HR2/HR2 interaction and prevents mitochondrial
tethering and subsequent fusion. In this context, it is expected that
overexpression of the HR1 segment alone would inhibit
mitochondrial fusion by binding to HR2 of endogenous Mfn2,
thereby resulting in fusion-defective, shorter and more fragmented
mitochondrial morphology. However, we found that few cells
transfected with Mfn2-HR1 contained fragmented mitochondria,
suggesting that the HR2 region of endogenous Mfn2 may not be
readily accessible for overexpressed HR1. In addition, the
overexpressed HR1 segment showed a diffuse distribution in the
cytosol without showing specific localizations (Fig. 5A). Interest-
ingly, many cells overexpressing Mfn2-HR1 contained more
elongated and entangled mitochondrial tubules compared to those
in untransfected control cells (Fig. 5A’, C). The similar phenotype
was observed in cells overexpressing Mfn2[360–448] (Fig. 5B’).
Cell counting indicated that more than half of the cells transfected
with Mfn2-HR1 or Mfn2[360–448] showed an elongated
mitochondrial phenotype (Fig. 5D). This observation suggests that
HR1 may bind to unknown cytosolic factors and affect
mitochondrial fusion/fission.
Mfn2 interacts with the fission protein DLP1
Overexpression of full length Mfn2 induces mitochondrial
elongation by increasing fusion (Fig. 3D). However, it is unlikely
that the HR1 segment lacking the GTPase domain directly
increases mitochondrial fusion by binding to endogenous Mfn2. It
is possible that overexpressed HR1 in the cytosol sequesters a
fusion inhibitory factor such as Mfn-binding protein (MIB) that
has been suggested to negatively regulate mitochondrial fusion
[38]. However, the region of the Mfn molecule binding to the MIB
is not known. Another possibility is that the elongated mitochon-
drial phenotype in cells overexpressing Mfn2-HR1 or Mfn2[360–
448] is due to decreased fission instead of increased fusion. This
raises the possibility that the overexpressed HR1 may interfere
with mitochondrial fission by interacting with the fission
machinery. We therefore tested a potential interaction of Mfn2
with fission proteins, DLP1 and Fis1. The Y2H analyses indicated
that there is a significant interaction between Mfn2 and DLP1,
whereas an interaction between Mfn2 and Fis1 was not detected
(Fig. 6A). The DLP1/DLP1 interaction was also evident as
reported previously [33]. Immunoprecipitation experiments
showed that a small amount of Mfn2 was co-precipitated with
DLP1 (Fig. 6B), suggesting that these two proteins interact with
each other probably in a transient manner.
Endogenous DLP1 distributes throughout the cytoplasm and a
sub-population is associated with mitochondria [3,5]. On the other
hand, it has been shown that overexpressed Mfn2 predominantly
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fluorescence staining of cells transfected with full length Myc-Mfn2
revealed clear enrichment of DLP1 in the clustered mitochondria
induced by Mfn2 overexpression (Fig. 6C–C’’), indicating that
DLP1 co-localized with Mfn2 in the clustered mitochondria. The
significant co-localization of DLP1 with Mfn2 was also observed in
elongated tubular mitochondria in cells transfected with Mfn2,
showing approximately 13% co-localization frequency of the total
pixels (Fig. 6D, D’). Because Mfn2 resides in the mitochondrial
outer membrane whereas DLP1 shuttles between the cytosol and
mitochondria, it is presumed that the Mfn2/DLP1 interaction that
we detected occurs at the mitochondrial surface.
We further tested Mfn2/DLP1 interaction in cells by bimolec-
ular fluorescence complementation (BiFC) in cells. BiFC detects
the fluorescent signal produced by two non-fluorescent fragments
of yellow fluorescent protein (YFP) when they are brought together
by interactions between two proteins fused to each YFP fragment
[39,40]. When G protein b and c subunits fused to N- and C-
Figure 3. Differential binding effects of three HR1 helix-breaking mutation. (A) Three leucine-to-proline mutations (L374P, L408P, and
L441P) made in each of the three predicted helices in the Mfn2[360–448]. (B) Y2H assays testing interactions of three HR1 mutants with Mfn2-HR2.
The Mfn2[360–448]-L374P and L408P disrupted the HR2 interaction whereas the L441P mutation maintained it. (C–H) Differential effects of three HR1
helix-breaking mutants on mitochondrial morphology. Clone 9 cells containing GFP-labeled mitochondria were transfected with Myc-tagged wild
type Mfn2, Mfn2-L374P, Mfn2-L408P, or Mfn2-L441P, and mitochondrial morphology was evaluated in transfected cells that were identified by anti-
Myc staining. (C) Cell counting for different mitochondrial morphologies among transfected cells. UT: untransfected. Error bars represent SEM. While
normal tubular mitochondria were seen in untransfected cells (D), overexpression of wild-type Mfn2 induced mitochondrial clustering (E) as well as
elongation of mitochondrial tubules (F). Mitochondria were overly elongated and entangled in the majority of cells overexpressing Mfn2-L374P (G) or
Mfn2-L408P (H). Cells overexpressing Mfn2-L441P contained fragmented mitochondria (I). Scale bar: 10 mm.
doi:10.1371/journal.pone.0020655.g003
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observed the cytoplasmic YFP fluorescence that was more
pronounced at the plasma membrane resulting from the Gb and
Gc interaction, indicating that the BiFC technique is suitable for
verifying protein interactions in cytoplasmic environment (Sup-
plemental Fig. S3A, B). Next, we fused Mfn2 to the N-terminal
Figure 4. Fusion competency of three Mfn2 mutants. Mfn DKO cells were transfected with Myc-tagged wild type or the three Mfn2 mutants,
and co-stained for Myc (red) and mitochondria (green). (A) Mitochondria in untransfected Mfn DKO cells are completely fragmented. UT:
untransfected. (B) Mitochondrial morphology quantification. Mfn2-L374P and Mfn2-L408P restored tubular mitochondria similar to or more effectively
than wild-type Mfn2. The majority of cells transfected with Mfn2-L441P still contained fragmented mitochondria, indicating that Mfn2-L441P is fusion
incompetent. Error bars represent SEM. (C–C’’) Mfn DKO cells expressing wild-type Mfn2. The transfected cell positive for Myc staining (C) contains
tubular mitochondria (C’). (D–D’’, E–E’’) Mfn DKO cells transfected with Mfn2-L374P (D) and Mfn2-L408P (E) show tubular mitochondria (D’, E’). (F–F’’)
Mitochondria in the Mfn DKO cell expressing Mfn2-L441P (F) remained fragmented (F’). T: transfected cells. Scale bar: 10 mm.
doi:10.1371/journal.pone.0020655.g004
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terminal fragment of YFP (YFP[159–238], YFP-C-DLP1), and
tested for BiFC by co-transfection (Fig. 7A). Many of the
transfected cells contained clustered mitochondria caused by
Mfn2 overexpression as reported previously [25,36,37]. While
overexpressed YFP-C-DLP1 filled the cytoplasm (Fig. 7B’’), we
observed a clear YFP fluorescence in clustered mitochondria,
demonstrating DLP1/Mfn2 interaction (Fig. 7BC). The YFP
signal was punctate within the mitochondrial clusters where it co-
localized with Mfn2, indicating that Mfn2 and DLP1 interact with
each other at specific sites of the mitochondrial surface. While
BiFC YFP was also observed in tubular mitochondria, it was
difficult to obtain these images due to weak signal and rapid
bleaching. Negative controls including single transfection of YFP-
N-Mfn2 or co-transfection of YFP-N-Mfn2 and YFP-C-Gc did not
show any BiFC YFP (results not shown). These results indicate that
the DLP1/Mfn2 interaction we detected is a bona fide cellular
event that takes place in the cytoplasm.
Role of DLP1 in mitochondria fusion
Further Y2H analyses revealed that Mfn2 interacts with the C-
terminal coiled coil domain of DLP1 (DLP1-CC) (Fig. 8A).
Analyses using different Mfn2 domains showed that DLP1
interacts with Mfn2-HR1, but not with Mfn2-GTPase or HR2
(Fig. 8B). Because both HR1 and HR2 contain coiled coil motifs
but only the HR1 interacts with DLP1, DLP1-CC interacts
specifically with Mfn2-HR1 rather than through a nonspecific
interaction between two coiled-coil regions. We narrowed down
the Mfn2-HR1 region that interacts with DLP1-CC to the
Mfn2[360–448] (Fig. 8C), which is the same region that interacts
with Mfn2-HR2. Co-immunoprecipitation verified the interaction
between DLP1-CC and Mfn2[360-448] (Fig. 8D).
Because Mfn2[360–448] interacts with DLP1, we tested the
effect of the three HR1 mutations on the DLP1 binding. Y2H
analyses revealed that L374P and L441P mutations abolished the
DLP1 binding whereas the L408P mutation did not affect the
DLP1 interaction (Fig. 8E). Additionally, we made these three
mutations in the full-length Mfn2 and tested their interactions with
the full-length DLP1. Both semi-quantitative and dilution series
Y2H analyses indicated that the full-length Mfn2-L374P and
Mfn2-L441P mutants have markedly reduced interactions with
DLP1 whereas the Mfn2-L408P mutant maintains the DLP1
interaction (Fig. 8F,G), consistent with the results obtained with
the HR1[360–448] domain. These data along with the HR1/HR2
interaction results (Fig. 3B) indicate that the three HR1 mutations
have differential interactions with DLP1 and Mfn2-HR2: the
L408P mutation abolished the interaction with Mfn2-HR2 but not
with DLP1-CC, whereas the L441P mutation disrupted the HR1/
DLP1-CC interaction while maintaining the HR1/HR2 interac-
tion. The L374P mutation disrupts both Mfn2-HR2 and DLP1-
CC interactions at the Mfn2-HR1. Additionally, we tested the
HR1 mutant segments for their abilities to induce mitochondrial
elongation. We found that Mfn2[360–448]-L374P and L441P
failed to induce the elongated mitochondrial phenotype whereas
L408P mutant was able to promote mitochondrial elongation
(Fig. 8H). These morphological data further indicate that L374P
and L441P mutations decrease the DLP1 interaction, and support
the notion that DLP1 interacts with the Mfn2 HR1 region to
induce mitochondrial elongation.
As mentioned earlier, the HR1/HR2 interaction is not
necessary for mitochondrial fusion because disruption of this
interaction by L374P or L408P mutation does not affect the fusion
capacity of Mfn2 (Fig. 3 and 4). On the other hand, the Mfn2-
L441P mutation that selectively abolishes the Mfn2/DLP1
interaction does not restore tubular mitochondria in Mfn DKO
cells (Fig. 4B, F–F’’), suggesting that the Mfn2/DLP1 interaction
plays a role in mitochondrial fusion. Because Mfn2-L441P
maintains the HR1/HR2 interaction, this result supports the
notion that the HR1/HR2 interaction is inhibitory of mitochon-
drial fusion. Interestingly, although both L374P and L441P
mutations disrupted the Mfn2/DLP1 interaction, Mfn2-L374P is
capable of mediating fusion (see Discussion).
Protein interactions and morphological data using Mfn2-HR1
mutations suggest that DLP1 may participate in mitochondrial
fusion by interacting with Mfn2. In order to further elaborate the
role of DLP1 in the fusion process, we examined mitochondrial
morphology in cells overexpressing wild type DLP1. If DLP1 were
solely a fission protein, overexpressed DLP1 would increase fission,
resulting in accumulation of small fragmented mitochondria.
Figure 5. Overexpression of Mfn2-HR1 or Mfn2[360–448]
induces an elongated and entangled mitochondrial pheno-
type. Clone 9 cells expressing GFP in the mitochondrial matrix were
transfected with Myc-Mfn2-HR1 (A–A’’) or Myc-Mfn2[360–448] (B–B’’),
and immunostained for the Myc-epitope. Both overexpressed domains
distribute to the cytosol due to the lack of membrane binding
information (A, B). Mitochondria in cells overexpressing these Mfn2
domains were overly elongated and collapsed (A’ and B’) compared to
those in untransfected control cells (C). Scale bar: 10 mm. (D)
Untransfected Clone 9 cells or cells transfected with Mfn2-HR1 or
Mfn2[360–448] were assessed for mitochondrial morphology. Approx-
imately 85% and 75% of cells overexpressing Mfn2-HR1 and Mfn2[360–
448], respectively, displayed elongated and collapsed mitochondrial
phenotype whereas the same phenotype was observed in about 10% of
untransfected cells. Error bars represent SEM.
doi:10.1371/journal.pone.0020655.g005
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mitochondria, and cells containing fragmented mitochondria were
rarely observed (Fig. 9C) [3,5]. Instead, we frequently observed
more elongated mitochondrial tubules in these cells (Fig. 9A’, C).
Approximately 45% of the DLP1 transfected cells showed
mitochondrial elongation. In addition, we observed long tubules
mixed with small fragmented mitochondria in about 20% of the
DLP1-overexpressing cells (Fig. 9B, C). This mitochondrial
phenotype suggests that increased number of DLP1 molecules
enhanced fusion in some tubules while participating in fission of
others within the same cell. We obtained more direct evidence for
DLP1 in mitochondrial fusion by examining mitochondrial
morphology in Mfn single knockout (KO) cells overexpressing
DLP1. Mitochondrial fusion still occurs in Mfn1 and Mfn2 single
KO cells that contain one Mfn isoform [41]. Both Mfn single KO
cell lines contain fragmented and very short tubules caused by a
reduction in fusion events [26,41]. We found that expression of
DLP1 in these Mfn single KO cells restores longer tubular
mitochondria, supporting the notion that DLP1 increases
mitochondrial fusion in these cells (Fig. 10A–B’’). Approximately
20% of Mfn1 KO cells transfected with DLP1 showed tubular
mitochondria (Fig. 10A’’). Surprisingly, the number of cells
containing longer mitochondrial tubules increased to 40% in
Mfn2 KO cells with DLP1 overexpression (Fig. 10B’’). In addition,
mitochondria in DLP1-overexpressing Mfn2 KO cells displayed a
more pronounced elongation (Fig. 10B’). Although the current
study has shown the interaction between DLP1 and Mfn2, these
data suggest that DLP1 may interact with both Mfn isoforms to
facilitate mitochondrial fusion (see Discussion). Mfn DKO cells
showed no tubular mitochondria with DLP1 overexpression due to
the complete absence of Mfn molecules (Fig. 10C–C’’).
Overall, in this study, we showed an interaction between two
heptad repeat regions of Mfn2-HR1 and HR2, and this interaction
plays an inhibitory role in mitochondrial fusion. In addition, we
found that the Mfn2-HR1 can also interact with the fission protein
DLP1, which suggests that the fission protein DLP1 has an
additional function in the fusion process through this interaction.
Discussion
Mfn2 is a multi-domain protein that mediates mitochondrial
fusion. Although the presence of domain interactions has been
suggested for Mfn proteins [34,37], no report has definitively shown
the HR1/HR2 interaction. A previous study indicated that the
Mfn2 lacking the TM and HR2 (GTPase-HR1) localized to the
mitochondria upon co-expression with the TM-HR2, suggesting a
potential HR1/HR2 interaction of Mfn2 [37]. In the current study,
we demonstrated that HR1 interacts directly withthe HR2 domain.
The overexpressed HR1 domain remained in the cytosol,
suggesting that the HR2 domain of endogenous Mfn2 is not readily
Figure 6. Mfn2 interacts with DLP1. (A) Semi-quantitative Y2H assays show that Mfn2 interacts with DLP1 but not with hFis1. The
transmembrane domain of Fis1 was deleted for the Y2H analyses. (B) Co-immunoprecipitation of Mfn2 and DLP1. BHK-21 cells transfected with Myc-
Mfn2 were subjected to immunoprecipitation using anti-DLP1 antibodies. Anti-Myc immunoblotting detected the presence of Myc-Mfn2 in the DLP1-
immune complex (asterisk) but not in the control (IgG, pA). WCE: whole cell extract. pA: protein A beads. (C–D’) Immunofluorescence staining shows
co-localization of Mfn2 and DLP1. Clone 9 cells transfected with Myc-Mfn2 were co-stained with anti-DLP1 (C) and anti-Myc (C’) antibodies. DLP1 is
enriched in the clustered mitochondria where it co-localizes with Mfn2 (C’’). In addition, some of the individual DLP1 puncta are co-localized with
punctate Myc-Mfn2 in cells containing tubular mitochondria (D). ImageJ Intensity Correlation Analysis for assessing the co-localization (D’). Scale bar:
10 mm. N: nucleus.
doi:10.1371/journal.pone.0020655.g006
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in the cytosol was unable to interfere with mitochondrial fusion and
instead induced elongated mitochondrial morphology, which led to
identifying the interaction of Mfn2 with the fission protein DLP1.
Our results demonstrated that Mfn2-HR1 interacts with not only
Mfn2-HR2 but also DLP1 at the mitochondrial surface. Three
point mutations in the Mfn2[360–448] revealed altered interactions
with Mfn2-HR2 and DLP1-CC. Although the detailed structure of
this region is undefined, it is possible that three a-helices in this
regionforma helixbundlethatpresentsbindingsitesforMfn2-HR2
and DLP1-CC. Because the mutation in the first helix disrupted
both interactions, it is possible that two binding sites share the first
helix. Due to small surface areas and an overlap of the two binding
sites, HR2 and DLP1-CC likely compete for the HR1 binding,
suggesting that binding affinities and local concentrations of these
binding domains play a role in differential interactions. It is possible
that HR1 isassociated withHR2inresting conditionsowing totheir
close proximity and that their dissociation may be accompanied by
the DLP1-CC interaction. Further detailed biochemical and
structural analyses will be necessary to define the interaction
characteristics of these binding domains.
It is interesting that selective disruptions of HR1/HR2 and
Mfn2/DLP1 interactions cause the opposite effects on mitochon-
drial morphology. Then, what would be the roles of the HR1/
HR2 and Mfn2/DLP1 interactions in mitochondrial fission and
fusion? It has been shown that mitochondrial fusion requires
tethering of opposing mitochondria mediated by the HR2/HR2
interaction of Mfn molecules [11]. In resting conditions, Mfn2-
HR1 may be associated with HR2, which we refer to as the
‘‘closed’’ conformation (Fig. 10D). Once HR2 is dissociated from
HR1 and becomes free (the ‘‘open’’ conformation), HR2 mediates
tethering and mitochondrial fusion can ensue. We speculate that
attaining the open conformation of Mfn2 proceeds to mitochon-
drial fusion, and that the DLP1-CC interaction at the Mfn2-HR1
is one of the mechanisms facilitating this process. It is possible that
interactions of HR2 and DLP1-CC at the HR1 are mutually
exclusive due to the overlapping binding sites. Therefore, the
DLP1-CC interaction at the HR1 would free up HR2 for
tethering and fusion (Fig. 10D). This model also explains the fusion
competence of Mfn2-L374P despite the abolition of DLP1
interaction by this mutation. Because the HR1/HR2 interaction
is also absent in Mfn2-L374P, this mutant takes the open
conformation and is able to mediate fusion.
An open question is how critical the Mfn2/DLP1 interaction is
in mitochondrial fusion. It is clear that the dominant role of DLP1
is in the fission process. Cells treated with DLP1 siRNA or DLP1
knockout cells show elongated mitochondrial tubules [42,43],
indicating a decrease of fission, not fusion. However, a small
change of the overall fission/fusion balance can result in a drastic
alteration in the terminal mitochondrial morphology [41,44].
Although the overly elongated mitochondria in DLP1-knockout or
knockdown cells are clearly a fission-defective phenotype, the
extent that the lack of DLP1 decrease mitochondrial fusion in
these cells is unknown. Possibly, DLP1-knockout/knockdown
decreases fission more than fusion, inducing elongated mitochon-
drial phenotype. Additionally, the notion that fusion is affected to
a lesser extent compared to fission upon DLP1 knockout/
knockdown suggests that the DLP1 binding to HR1 is not the
sole mechanism to dissociate the HR1/HR2 interaction promot-
ing mitochondrial fusion.
Intriguing morphological changes brought about by overexpres-
sion of wild type DLP1 indicates that DLP1 can act as a fusion
factor. Contrary to the idea that mitochondrial fission should
increase upon overexpressing DLP1, fragmented mitochondria
were rarely observed in DLP1-overexpressing cells as shown before
[3,5]. While the absence of mitochondrial fragmentation in these
Figure 7. BiFC demonstrating the Mfn2/DLP1 interaction in cells. (A) Constructs used for the BiFC detection of the Mfn2/DLP1 interaction.
The YFP N-terminal fragment (YFP[1–158]) was fused to Myc-Mfn2 (YFP-N-Mfn2), and the YFP C-terminal fragment (YFP[159–238]) to HA-DLP1 (YFP-C-
DLP1). (B–C’’) BHK-21 cells were co-transfected with YFP-N-Myc-Mfn2 and YFP-C-HA-DLP1 and immunostained for Myc (B’, C’) and DLP1 (B’’).
Mitochondrial clusters of co-transfected cells show bright punctate YFP signal (B, C). White lines demarcate the cell boundary. The ImageJ Intensity
Correlation Analysis was used for assessing co-localization (C’’). N: nucleus. Scale bars: 10 mm.
doi:10.1371/journal.pone.0020655.g007
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receptor Fis1 or Mff, the most noticeable mitochondrial morphol-
ogy in DLP1-overexpressing cells was elongated tubules that were
often collapsed around the nucleus (Fig. 9A’). This mitochondrial
phenotype suggests that excess DLP1 that does not engage in fission
(limited by the number of Fis1/Mff molecules) may increase fusion
by interacting with Mfn2. By overexpressing DLP1 in Mfn single
KO cells, more direct evidence for the role of DLP1 in
mitochondrial fusion was obtained (Fig. 10). Restoring long tubular
mitochondria by increasing the number of DLP1 molecules in Mfn
single KO cells containing residual fusion activity provides strong
evidence for the role of DLP1 in facilitating fusion. Another
interesting finding was that DLP1 could also interact with the Mfn1
isoform, as DLP1 overexpression in Mfn2 KO cells form markedly
elongated mitochondria (Fig. 10B’). Mfn1 and Mfn2 are highly
similar to each other in their domain structures, and both
homomeric and heteromeric complexes mediate mitochondrial
fusion [12,26,45]. Mfn1 has been shown to be more ubiquitously
expressed throughout mammalian tissues as well as in fibroblasts
and cell lines whereas Mfn2 are more tissue specific showing high
abundance in the heart [27]. The more pronounced effect of
mitochondrial elongation in Mfn2 KO cells containing only the
Mfn1 isoform suggests that DLP1 interacts with Mfn1 more
efficiently or that Mfn1 may be more abundant than Mfn2 in this
fibroblast cell line. Further studies are necessary to verify whether
Mfn1 has similar interaction characteristics to Mfn2 intra-
molecularly and with DLP1. Regardless, the mitochondrial
phenotype induced by DLP1 overexpression supports the notion
that DLP1 can participate in the fusion process in addition to its
function as the fission protein.
An extended scenario based on this model is that DLP1 can be a
regulatory factor determining fission or fusion by binding
differentially to Fis1/Mff and Mfn2. DLP1 has been shown to
be in close proximity to Mfn2 [46], indicating the presence of a
fission/fusion microenvironment at the mitochondrial surface. It is
possible that fission and fusion machineries stay close together on
the mitochondrial membrane, poised to execute either fission or
fusion upon specific cellular cues. For efficient execution of fission
or fusion, it would be necessary to activate the one process while
concomitantly suppressing the other. Interaction of DLP1 with
Mfn2 would allow mitochondrial fusion as discussed above. At the
same moment, the DLP1/Mfn2 interaction would decrease the
Figure 8. Identification of binding regions in DLP1 and Mfn2, and differential binding of the three HR1 mutants to DLP1. Y2H
analyses show that Mfn2DTM and DLP1 bind to DLP1-CC (A) and Mfn2-HR1 (B), respectively. (C) Dilution series Y2H analyses show that DLP1-CC binds
to Mfn2[360–448]. (D) Co-immunoprecipitation of DLP1-CC and Mfn2[360–448]. Whole cell extract (WCE) from BHK-21 cells co-transfected with HA-
tagged DLP1-CC and Myc-tagged Mfn2[360–448] was subjected to anti-HA immunoprecipitation. Myc-Mfn2[360–448] was co-precipitated (asterisk)
with HA-DLP1-CC. (E-G) Y2H analyses for interactions of the HR1 mutants with DLP1 using binding segments (E) and full-length proteins (semi-
quantitative: F and dilution series: G). L374P and L441P disrupted the DLP1 interactions whereas the L408P mutation maintains this interaction (E). (H)
Clone 9 cells expressing mitochondrial GFP were transfected with Mfn2[360–448]-WT, L374P, L408P, or L441P and mitochondrial morphology was
assessed for the elongated phenotype. Overexpression of WT and L408P induced mitochondrial elongation whereas significantly decreased
elongation was observed with L374P and L441P mutations. Error bars represent SEM.
doi:10.1371/journal.pone.0020655.g008
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vironment, thereby efficiently shifting the balance to the fusion
process (Fig. 10D). In the same way, an efficient shift to fission
would occur when DLP1 interacts with Fis1/Mff. A similar
mechanism has been reported for the membrane fission dynamin
Vps1p participating in yeast vacuole fusion, in which a reversible
interaction of Vps1p with a fusion t-SNARE protein promotes
membrane fusion with a concomitant inhibition of fission [35].
In this study, we identified previously unrecognized interactions
involving fusion and fission proteins, Mfn2 and DLP1. Our results
show that Mfn2-HR1 interacts with HR2 and DLP1-CC, and that
these interactions regulate mitochondrial morphology. Many
questions still remain, including the mechanisms regulating the
differential interactions, multimeric states of Mfn2/DLP1/Fis1
involved in these interactions, and Mfn isoform specificity for these
molecular interactions. Several phosphorylation events have been
suggested within the binding regions of Mfn2 and DLP1, most
notably the serine 442 in the Mfn2-HR1 [23,47–50]. Differential
phosphorylation within the binding domains of Mfn2 and DLP1 in
response to different cellular signals may regulate these interac-
tions to control mitochondrial morphology. While further study is
necessary, the current study presents the first evidence for the
interaction between mitochondrial fission and fusion proteins, and
provides a novel insight as to how the physical and functional
communications of fission and fusion machineries at the fission/
fusion site regulate mitochondrial morphology.
Materials and Methods
Cell lines and transfection
Clone 9 (ATCC CRL-1439) and BHK-21 cells (ATCC CCL-
10) were maintained in Ham’s F-12K and Dulbecco’s modified
Eagle’s media, respectively. Mfn1 and Mfn2 single and double
knockout mouse embryonic fibroblasts were obtained from Dr.
David Chan (California Institute of Technology). Cell culture
media were supplemented with 10% fetal bovine serum,
nonessential amino acids, L-glutamine and penicillin/streptomy-
cin. Clone 9 cells stably expressing mitochondrial matrix-targeted
GFP were maintained in 200 mg/ml G418 [8]. Transfection was
performed using lipofectamine (Invitrogen, Inc.) according to the
manufacturer’s instruction.
Plasmid construction
Standard PCR-based amplification and subcloning techniques
were used for plasmid construction. Correct sequences of
subcloned DNA were verified by DNA sequencing. For yeast
two-hybrid constructs, DNA fragments encoding indicated Mfn2,
DLP1, and hFis1 regions were cloned into yeast pGADT7 and
pGBKT7 vectors that contain LEU2 and TRP1, respectively, as
nutritional selection markers (Clontech). The mammalian expres-
sion vector pcDNA3 (Invitrogen) was used as a backbone plasmid
for all the constructs used for mammalian cell transfection.
Yeast two-hybrid procedure
Matchmaker
TM Two-Hybrid System 3 (Clontech) was used for
two-hybrid studies. Standard yeast genetic techniques and media
were used. SD (synthetic dropout) and YPD media supplemented
with 2% dextrose were prepared as described previously [51].
AH109 (MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4D,
gal80D, LYS2 : : GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-
ADE2, URA3 : : MEL1UAS-MEL1TATA-lacZ) was used as yeast host
strain. Lithium acetate-mediated yeast transformation was used
according to Yeast Protocols Handbook (Clontech User Manual).
Western blot analysis was used to confirm the expression of the
proper constructs in host strain after transformation. Interactions
between bait and prey proteins were evaluated by growth in SD/
-Leu/-Trp/-His. Briefly, yeast transformants grown in the SD/
-Leu/-Trp liquid media was collected and resuspended at a
density of 1.0 OD unit/ml at 600 nm. For semi-quantitative
analyses, 50 ml of the 1:625 dilution was spread onto both SD/
-Leu/-Trp and SD/-Leu/-Trp/-His plates, and ratios of the
colony numbers on the SD/-Leu/-Trp/-His plate and the SD/
-Leu/-Trp plate were used for indications of the interaction
strength. For serial dilution assays, the 1:5 serial dilutions were
spotted onto the SD/-Leu/-Trp/-His plate and grown for four
days for visual assessment of interactions.
Immunoprecipitations
Appropriate DNA constructs were transfected to BHK-21 cells
and expressed for 24 hours. Cell lysates were prepared in PBS
containing 1% Triton X-100 and protease inhibitors cocktail
(Sigma-Aldrich) and cleared by centrifugation. The supernatant
(whole cell extract) was incubated with anti-HA or anti-DLP1
antibodies, and the immune complex was isolated with Protein A-
Sepharose (Sigma-Aldrich). Normal rabbit IgG was added in place
of antibodies for negative control experiments. Where necessary,
whole cell extract was pre-cleared by rabbit IgG and Pansorbin
(CalBiochem) before incubating with antibodies. In some exper-
iments, Protein A-conjugated magnetic beads (Invitrogen) were
used instead of the Protein A-Sepharose. After washing, bead-
bound immune complex was eluted using 200 mM glycine
(pH 2.0) for immunoblot analyses.
Indirect immunofluorescence
Indirect immunofluorescence was performed as previously
described [4,7]. Cells were grown on glass coverslips for 16–24 h
Figure 9. Overexpression of DLP1 induces mitochondrial
elongation. Clone 9 cells expressing GFP in the mitochondrial matrix
were transfected with untagged full-length wild type DLP1, and
immunostained for DLP1. Overexpression of DLP1 induces the
formation of elongated and entangled mitochondria (A, A’). A DLP1-
overexpressing cell shown in (B) contains long tubular mitochondria
along with short fragmented ones. Cell counting indicates that DLP1
overexpression increased mitochondrial elongation (C). Error bars
represent SEM. ‘T’ denotes transfected cells. Scale bars: 10 mm.
doi:10.1371/journal.pone.0020655.g009
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(Electron Microscopy Sciences) and permeabilized with 0.1% Triton
X-100 (Pierce Biotechnology). After blocking, cells were incubated
with primary and then secondary antibodies. Mouse anti-Myc
(Sigma-Aldrich), human anti-mitochondria [5], and/or rabbit anti-
DLP1 were used as the primary antibody and Alexa 488- or Alexa
Figure 10. Role of DLP1 in mitochondrial fusion. Mfn1 and 2 single KO cells (mouse embryonic fibroblasts) were transfected with wild type
DLP1 and immunostained for DLP1 and cytochrome c for mitochondrial morphology. Mitochondria became longer in Mfn1 KO (A–A’’) and Mfn2 KO
cells (B–B’’) overexpressing DLP1 (arrows), whereas those in adjacent untransfected cells were short and fragmented. More marked elongation of
mitochondria is apparent in Mfn2 KO cells overexpressing DLP1 (B’). Mfn DKO cells showed completely fragmented mitochondria with DLP1
overexpression (C–C’’). Error bars represent SEM. ‘T’ denotes transfected cells. Scale bars: 10 mm. (D) A schematic model describing the regulatory
function of DLP1 in mitochondrial fusion and fission. Fission/fusion machineries are in close proximity in the mitochondrial membrane. The HR1/HR2
interaction keeps Mfn2 molecules in the ‘‘closed’’ conformation. The closed conformation could be formed by intra- or inter-molecular HR1/HR2
interaction (Supplemental Fig. S1). Although only the monomeric Mfn2 is shown here, Mfn2 possibly works in a multimeric conformation for the
fusion reaction. DLP1 displaces the HR2 at the HR1 to induce the ‘‘open’’ conformation of Mfn2, which allows the HR2 to associate with the HR2 in
opposing mitochondria for tethering and outer membrane fusion. During this process, DLP1 becomes locally and temporarily unavailable for Fis1,
effectively suppressing the fission process. In the same way, the efficient fission occurs when DLP1 interacts with Fis1.
doi:10.1371/journal.pone.0020655.g010
A Novel Mechanism Controlling Mitochondrial Shape
PLoS ONE | www.plosone.org 12 May 2011 | Volume 6 | Issue 5 | e20655594-conjugated anti-mouse, anti-rabbit or anti-human IgG (Molec-
ular Probes Inc.) for secondary antibodies. After rinsing, coverslips
were mounted in ProLong antifade reagent (Molecular Probes Inc.)
onglass slides.Fluorescence images were acquired with an Evolution
QEi camera (Mediacybernetics, Inc.) and analyzed/adjusted using
ImageJ (Wayne Rasband, NIH) and Adobe Photoshop (Adobe
Systems Inc.) software.
Supporting Information
Figure S1 Intra- and inter-molecular interactions of
Mfn2 involving HR1 and HR2. (A) GST-HR2 was incubated
with 6xHis-tagged HR1 and HR1-HR2 separately or with the
mixture of the two proteins. Bound proteins were pulled down
with glutathione beads and analyzed by anti-His immunoblotting.
In: input, B: bound. GST-HR2 pulled down HR1 and HR2 in
separate incubations. HR2 binds preferentially to HR1 in the
incubation with the mixture of HR1 and HR1-HR2. (B) Mfn2-
HR1 and HR2 may be associated within the same molecule by an
intra-molecular interaction. The anti-parallel HR1/HR2 interac-
tion between two Mfn2 molecules would form the dimeric
configuration whereas parallel HR1/HR2 interactions lead to
the multimeric configuration.
(TIF)
Figure S2 Morphometric analyses for mitochondrial
shapes induced by Mfn2 mutants. Form factor (FF) and
Aspect ratio (AR) have a minimal value of 1 when it is a small
perfect circle and the values increase as mitochondria become
elongated. AR is a measure of mitochondrial length, and increase
of FF represents increase of mitochondrial length as well as
branching. Mitochondria in cells expressing WT, L374P or L408P
have increased values of both AR and FF compared to
untransfected (UT) cells whereas those of cells expressing L441P
have the value close to 1 for small circular morphology. The
number of mitochondria increased in the Mfn2-L441P mutant
cells, indicating mitochondrial fragmentation, whereas the num-
bers decreased with expression of the other mutants and wild type
for an increased fusion.
(TIF)
Figure S3 BiFC by interaction of Gb and Gc. (A and B) G
protein b and c subunits fused to N- and C-terminal fragments of
YFP as a positive control. Upon co-transfection of positive control
plasmids, the cytoplasmic YFP fluorescence with a concentration
at the cell cortex was observed, indicating that Gb and Gc interact
in cells pronouncedly at the plasma membrane.
(TIF)
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